STOCKSCREENR
Log In

MYNZ

NASDAQ

Mainz Biomed B.V.

$0.70-0.04(-5.07%)Mkt Cap: $2.86M

Key Stats

Market Cap

$2.86M

P/E Ratio

-0.13

EPS

$-5.28

Dividend Yield

0.00%

52-Week Range

$0.55 — $5.34

Volume

21.83K

Avg Volume

554.37K

Beta

0.32

Valuation

P/E (TTM)

-0.13

Forward P/E

—

PEG Ratio

-0.00

P/S (TTM)

4.37

P/B (TTM)

0.88

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-4.43%

ROA (TTM)

-1.94%

ROIC

—

Gross Margin

-0.08%

Operating Margin

-25.73%

Net Margin

—

Debt/Equity

1.23

Current Ratio

0.52

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-4.26%

EPS Growth (5Y)

-8.92%

Sales Growth (3Y)

+0.20%

Sales Growth (5Y)

+0.31%

EPS Est (This Year)

$-1.35

EPS Est (Next Year)

$-1.47

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.61

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

4.09M

Float

3.77M

Free Float %

92.14%

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

DE

Exchange

NASDAQ

IPO Date

2021-11-05

Employees

19

CEO

Guido Baechler

Index Membership

—

Website

https://mainzbiomed.com

Mainz Biomed B.V. (MYNZ) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $2.86M, a P/E ratio of -0.13, MYNZ is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MYNZ against other stocks using dozens of fundamental and technical filters.

Similar Stocks

TRIB

Trinity Biotech plc

$0.75

+1.05%

$7.79M

MBAI

Check-Cap Ltd. Ordinary Share

$1.70

-3.41%

$9.95M

NDRA

ENDRA Life Sciences Inc.

$3.31

-0.44%

$2.49M

VRCI.L

Verici Dx plc

$0.57

+0.00%

$8.70M

PRM.L

Proteome Sciences plc

$1.64

-5.22%

$4.30M

AGL.L

ANGLE plc

$0.94

-1.58%

$3.02M

Frequently Asked Questions

What is Mainz Biomed B.V.'s P/E ratio?

Mainz Biomed B.V. (MYNZ) has a trailing twelve-month (TTM) P/E ratio of -0.13. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Mainz Biomed B.V. pay a dividend?

No, Mainz Biomed B.V. (MYNZ) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Mainz Biomed B.V.'s market cap?

Mainz Biomed B.V. (MYNZ) has a market capitalization of $2.86 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.